// App-Quantinova.ai

: CSIG-26. IS INTRINSIC APOPTOSIS THE SIGNALING PATHWAY ACTIVATED BY TUMOR-TREATING FIELDS FOR GLIOBLASTOMA?

Researchers

Presenter

  • Kristen Carlson

Principal Investigators

  • Jack Tuszynski

  • Zeev Bomzon

Medical Centers

  • Harvard Medical School, Boston, MA

  • University of Alberta, Edmonton, AB, Canada

  • Novocure, Haifa, Israel

Locations

  • United States

  • Canada

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

Biomarkers

  • B-cell lymphoma 2

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Celecoxib

  • ALT-210

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved